Loading…
Baxter International Inc. is projected to rise to $22.10 by 2027, a +14% move from its current price of $19.33. BAX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $18.95 | $19.33 | $19.73 | +0.01% |
| May 30 | $18.79 | $19.33 | $19.89 | +0.02% |
| May 31 | $18.67 | $19.34 | $20.02 | +0.03% |
| Jun 1 | $18.57 | $19.34 | $20.13 | +0.04% |
| Jun 2 | $18.49 | $19.34 | $20.23 | +0.05% |
| Jun 3 | $18.41 | $19.34 | $20.32 | +0.06% |
| Jun 4 | $18.34 | $19.34 | $20.40 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $18.34 | $19.34 | $20.40 | +0.07% |
| Week 2 | $17.95 | $19.36 | $20.87 | +0.13% |
| Week 3 | $17.66 | $19.37 | $21.24 | +0.20% |
| Week 4 | $17.42 | $19.38 | $21.56 | +0.26% |
| Week 5 | $17.21 | $19.39 | $21.85 | +0.33% |
| Week 6 | $17.03 | $19.41 | $22.11 | +0.39% |
| Week 7 | $16.86 | $19.42 | $22.36 | +0.46% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Its products include sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories.
Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand.
Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Baxter International Inc. (BAX) is a healthcare company with a current price of $19.18 and a market cap of $9.91B, ranking 918. The stock’s price action is embedded in a forecast that shows a path from 2026 onward with rising averages and bullish milestones, including a 2030 average price of $28.83 and a 2040 average of $73.37 and a 2050 average of $125.66.
As of the latest data, the 2026 average price is $19.18 (Neutral), with 2027 $22.04 (Neutral), 2028 $22.96 (Neutral), 2029 $25.83 (Bullish), 2030 $28.83 (Bullish). The long-run trajectory extends to 2031 $33.46, 2032 $40.17, 2033 $41.05, 2034 $42.07, 2035 $47.04, 2040 $73.37, and 2050 $125.66, with escalating ROIs at each step (e.g., 2030 ROI 50.3, 2040 ROI 282.5, 2050 ROI 555.1).
A major floor 18.9% below — a decisive break under it would weaken the trend.
The nearest floor, 14.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.3% away) — a breakout level to watch.
A major ceiling 15.2% above — clearing it would confirm fresh momentum.
Key BAX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BAX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.14 | Buy | $19.06 | Buy |
| MA 10 | $18.42 | Buy | $18.65 | Buy |
| MA 20 | $17.86 | Buy | $18.24 | Buy |
| MA 50 | $17.54 | Buy | $18.09 | Buy |
| MA 100 | $18.75 | Buy | $18.70 | Buy |
| MA 200 | $20.05 | Sell | $20.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.89 | Neutral |
| Stoch RSI (14) | 96.12 | Sell |
| CCI (20) | 139.41 | Buy |
| Williams %R (14) | -2.40 | Info |
| MACD (12,26,9) | 0.21 | Buy |
| ROC (12) | 7.45 | Buy |
| Bollinger %B (20,2) | 0.93 | Neutral |
| Stochastic %K (14) | 97.60 | Sell |
| TRIX (15) | 0.15 | Buy |
| Awesome (5,34) | 1.20 | Buy |
| Ultimate (7,14,28) | 84.12 | Sell |
| Momentum (10) | 1.44 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 19.65 | Sell |
| ADX (14) | 14.38 | Neutral |
| ATR (14) | 0.36 | Info |
30-day technical picture shows bullish sentiment. RSI(14) is 60, suggesting upside momentum, with the SMA50 at $17.46 and the SMA200 at $20.09. The stock’s near-term support stands at $16.62 and resistance at $19.18. The 30-day price range spans from $16.67 to $22.07, and the annualized volatility is 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.80 | $19.33 | $24.46 | 0% | Neutral | |
| $17.97 | $22.10 | $28.50 | +14% | Neutral | |
| $18.22 | $22.84 | $30.27 | +18% | Neutral | |
| $20.12 | $25.63 | $34.73 | +33% | Bullish | |
| $22.09 | $28.55 | $39.40 | +48% | Bullish | |
| $25.10 | $32.86 | $46.10 | +70% | Bullish | |
| $29.80 | $39.49 | $56.22 | +104% | Bullish | |
| $30.26 | $40.56 | $58.52 | +110% | Bullish | |
| $30.47 | $41.28 | $60.31 | +114% | Bullish | |
| $33.55 | $45.91 | $67.86 | +138% | Bullish | |
| $49.84 | $71.36 | $110.78 | +269% | Bullish | |
| $78.61 | $121.46 | $202.75 | +528% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $15.80 | $19.33 | $22.71 | +0.00% |
| June 2026 | $16.80 | $19.62 | $23.38 | +1.52% |
| July 2026 | $16.59 | $19.50 | $23.46 | -0.65% |
| August 2026 | $16.79 | $19.82 | $24.03 | +1.65% |
| September 2026 | $16.91 | $20.05 | $24.46 | +1.16% |
| October 2026 | $16.48 | $19.61 | $24.07 | -2.19% |
| November 2026 | $16.22 | $19.36 | $23.88 | -1.25% |
| December 2026 | $16.49 | $19.74 | $24.46 | +1.92% |
Click any year to see its month-by-month BAX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BAX to range from $15.80 to $24.46 through 2026. The $19.33 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BAX price prediction for 2027 points to an average of $22.10 (low $17.97, high $28.50) — a potential gain of +14% on today's $19.33. A consolidation phase looks the most probable path here.
In 2028, BAX is projected to trade between $18.22 and $30.27, averaging $22.84 — a potential gain of +18% from today's $19.33. That is up +3% on the projected 2027 average. Price action looks broadly range-bound.
Baxter International Inc.'s 2029 outlook centres on $25.63, within a $20.12 to $34.73 range. That is up +12% on the projected 2028 average. That marks a +33% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, BAX could reach as high as $39.40, with a base case around $28.55 and support toward $22.09 — roughly +48% from $19.33. Momentum favours further upside here.
Expect BAX to range from $25.10 to $46.10 through 2031. The $32.86 average target implies a +70% move from current prices. That is up +15% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The BAX price prediction for 2032 points to an average of $39.49 (low $29.80, high $56.22) — a potential gain of +104% on today's $19.33. Momentum favours further upside here.
In 2033, BAX is projected to trade between $30.26 and $58.52, averaging $40.56 — a potential gain of +110% from today's $19.33. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Baxter International Inc.'s 2034 outlook centres on $41.28, within a $30.47 to $60.31 range. That is up +2% on the projected 2033 average. That marks a +114% change versus current levels. Momentum favours further upside here.
By 2035, BAX could reach as high as $67.86, with a base case around $45.91 and support toward $33.55 — roughly +138% from $19.33. Buyers look set to stay in control over this stretch.
Expect BAX to range from $49.84 to $110.78 through 2040. The $71.36 average target implies a +269% move from current prices. That is up +55% on the projected 2035 average. Momentum favours further upside here.
The BAX price prediction for 2050 points to an average of $121.46 (low $78.61, high $202.75) — a potential gain of +528% on today's $19.33. Buyers look set to stay in control over this stretch.
Investing $1,000 in BAX today (≈ 51.733057 BAX) could be worth
$6,283.44
+$5,283.44 (+528%) by 2050 · US Dollar
Based on the average projected BAX price of $121.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BAXwould be worth at today's price.
$1,000 invested in BAX on May 27, 2025 (≈ 32.393909 BAX) would be worth
$626.17
-$373.83 (-37.4%) today · 0.63× · US Dollar
Based on a BAX entry price of $30.87 vs. today's $19.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.77 | $1,029.83 | +3.0% |
| 1 month ago | $18.49 | $1,045.43 | +4.5% |
| 3 months ago | $20.36 | $949.41 | -5.1% |
| 6 months ago | $18.74 | $1,031.48 | +3.1% |
| 1 year ago | $30.87 | $626.17 | -37.4% |
| All time (5.0y) ago | $82.14 | $235.33 | -76.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BAX forecast.
Our base-case forecast reaches $39.00 around 2032.
Implied market cap at $39.00: $20.14B
The multi-year forecast depicts a clear uptrend with rising averages and bullish sentiment from 2029 onward. The 2030 average price is $28.83 with an ROI of 50.3, followed by 2031 at $33.46 (ROI 74.5), 2032 at $40.17 (ROI 109.4), 2033 at $41.05 (ROI 114), 2034 at $42.07 (ROI 119.3), and 2035 at $47.04 (ROI 145.3). The trajectory accelerates toward the 2040 milestone of $73.37 (ROI 282.5) and the 2050 milestone of $125.66 (ROI 555.1).
These figures imply meaningful upside over the long term, but they are estimates, not guarantees, and are subject to market risk and other factors.
Tap a question to reveal the answer.
In 2030, the average price is forecast to be $28.83 with a min of $22.14 and a max of $40.16; ROI 50.3; sentiment BULLISH.
The forecast shows a longer-term bullish path with a 2030 avg of $28.83, a 2040 avg of $73.37, and a 2050 avg of $125.66, along with ROIs of 50.3 (2030), 282.5 (2040), and 555.1 (2050). These are estimates, not guarantees.
Yes. The 2050 forecast shows an average price of $125.66 and a max of $213.46, indicating the potential to exceed $100 under the projection.
Current price $19.18; Market cap $9.91B.
30-day range: low $16.67, high $22.07.
Baxter International Inc. Community Discussion
0Share your Baxter International Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.